| # | Title | Journal | Year | Citations |
|---|
| 1 | Updated national birth prevalence estimates for selected birth defects in the United States, 2004–2006 | Birth Defects Research Part A: Clinical and Molecular Teratology | 2010 | 1,503 |
| 2 | National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999–2001 | Birth Defects Research Part A: Clinical and Molecular Teratology | 2006 | 547 |
| 3 | Guidelines for case classification for the national birth defects prevention study | Birth Defects Research Part A: Clinical and Molecular Teratology | 2003 | 501 |
| 4 | Seeking causes: Classifying and evaluating congenital heart defects in etiologic studies | Birth Defects Research Part A: Clinical and Molecular Teratology | 2007 | 367 |
| 5 | An update to the list of mouse mutants with neural tube closure defects and advances toward a complete genetic perspective of neural tube closure | Birth Defects Research Part A: Clinical and Molecular Teratology | 2010 | 285 |
| 6 | Mouse mutants with neural tube closure defects and their role in understanding human neural tube defects | Birth Defects Research Part A: Clinical and Molecular Teratology | 2007 | 273 |
| 7 | Epidemiology of bronchopulmonary dysplasia | Birth Defects Research Part A: Clinical and Molecular Teratology | 2014 | 262 |
| 8 | Teratogen update: Lead and pregnancy | Birth Defects Research Part A: Clinical and Molecular Teratology | 2005 | 245 |
| 9 | Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations | Birth Defects Research Part A: Clinical and Molecular Teratology | 2007 | 230 |
| 10 | Trends in the postfortification prevalence of spina bifida and anencephaly in the United States | Birth Defects Research Part A: Clinical and Molecular Teratology | 2008 | 229 |
| 11 | A systematic review to calculate background miscarriage rates using life table analysis | Birth Defects Research Part A: Clinical and Molecular Teratology | 2012 | 224 |
| 12 | Angiotensin II receptor antagonist treatment during pregnancy | Birth Defects Research Part A: Clinical and Molecular Teratology | 2005 | 219 |
| 13 | Congenital minamata disease: Intrauterine methylmercury poisoning | Birth Defects Research Part A: Clinical and Molecular Teratology | 2010 | 207 |
| 14 | In vitro fertilization (IVF) in Sweden: Risk for congenital malformations after different IVF methods | Birth Defects Research Part A: Clinical and Molecular Teratology | 2005 | 206 |
| 15 | Maternal age and non-chromosomal birth defects, Atlanta?1968-2000: Teenager or thirty-something, who is at risk? | Birth Defects Research Part A: Clinical and Molecular Teratology | 2004 | 204 |
| 16 | Epigenomic disruption: The effects of early developmental exposures | Birth Defects Research Part A: Clinical and Molecular Teratology | 2010 | 201 |
| 17 | Review: Hyperthermia and fever during pregnancy | Birth Defects Research Part A: Clinical and Molecular Teratology | 2006 | 199 |
| 18 | Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities | Birth Defects Research Part A: Clinical and Molecular Teratology | 2004 | 189 |
| 19 | Early pregnancy azathioprine use and pregnancy outcomes | Birth Defects Research Part A: Clinical and Molecular Teratology | 2009 | 188 |
| 20 | The national birth defects prevention study: A review of the methods | Birth Defects Research Part A: Clinical and Molecular Teratology | 2015 | 188 |
| 21 | Changes in the birth prevalence of selected birth defects after grain fortification wiht folic acid in the United States: Findings from a multi-state population-based study | Birth Defects Research Part A: Clinical and Molecular Teratology | 2005 | 186 |
| 22 | Holoprosencephaly: Clinical, anatomic, and molecular dimensions | Birth Defects Research Part A: Clinical and Molecular Teratology | 2006 | 182 |
| 23 | Extracellular matrix and heart development | Birth Defects Research Part A: Clinical and Molecular Teratology | 2011 | 182 |
| 24 | Maternal influenza during pregnancy and risk of congenital abnormalities in offspring | Birth Defects Research Part A: Clinical and Molecular Teratology | 2005 | 180 |
| 25 | Cryptorchidism and hypospadias as a sign of testicular dysgenesis syndrome (TDS): Environmental connection | Birth Defects Research Part A: Clinical and Molecular Teratology | 2010 | 177 |
| 26 | Decline in the prevalence of neural tube defects following folic acid fortification and its cost‐benefit in South Africa | Birth Defects Research Part A: Clinical and Molecular Teratology | 2008 | 176 |
| 27 | Zebrafish as a model for developmental neurotoxicity testing | Birth Defects Research Part A: Clinical and Molecular Teratology | 2006 | 174 |
| 28 | Pregnancy outcomes following systemic prenatal acyclovir exposure: Conclusions from the international acyclovir pregnancy registry, 1984-1999 | Birth Defects Research Part A: Clinical and Molecular Teratology | 2004 | 167 |
| 29 | The relationship between sonic Hedgehog signaling, cilia, and neural tube defects | Birth Defects Research Part A: Clinical and Molecular Teratology | 2010 | 165 |
| 30 | Pregnancy outcome of women exposed to azathioprine during pregnancy | Birth Defects Research Part A: Clinical and Molecular Teratology | 2007 | 164 |
| 31 | Maternal periconceptional smoking and alcohol consumption and risk for select congenital anomalies | Birth Defects Research Part A: Clinical and Molecular Teratology | 2008 | 163 |
| 32 | Maternal fumonisin exposure and risk for neural tube defects: Mechanisms in an in vivo mouse model | Birth Defects Research Part A: Clinical and Molecular Teratology | 2005 | 162 |
| 33 | Extremely high prevalence of neural tube defects in a 4-county area in Shanxi Province, China | Birth Defects Research Part A: Clinical and Molecular Teratology | 2006 | 162 |
| 34 | Teratogen update: Methotrexate | Birth Defects Research Part A: Clinical and Molecular Teratology | 2012 | 160 |
| 35 | Prenatal choline supplementation mitigates behavioral alterations associated with prenatal alcohol exposure in rats | Birth Defects Research Part A: Clinical and Molecular Teratology | 2010 | 154 |
| 36 | Paper 4: EUROCAT statistical monitoring: Identification and investigation of ten year trends of congenital anomalies in Europe | Birth Defects Research Part A: Clinical and Molecular Teratology | 2011 | 152 |
| 37 | Microtia‐anotia: A global review of prevalence rates | Birth Defects Research Part A: Clinical and Molecular Teratology | 2011 | 152 |
| 38 | Understanding dioxin developmental toxicity using the zebrafish model | Birth Defects Research Part A: Clinical and Molecular Teratology | 2006 | 151 |
| 39 | Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects | Birth Defects Research Part A: Clinical and Molecular Teratology | 2012 | 151 |
| 40 | Health care expenditures of children and adults with spina bifida in a privately insured U.S. population | Birth Defects Research Part A: Clinical and Molecular Teratology | 2007 | 145 |
| 41 | First trimester exposure to corticosteroids and oral clefts | Birth Defects Research Part A: Clinical and Molecular Teratology | 2003 | 136 |
| 42 | Genetic polymorphisms: Impact on the risk of fetal alcohol spectrum disorders | Birth Defects Research Part A: Clinical and Molecular Teratology | 2005 | 134 |
| 43 | A consideration of the evidence that genetic defects in planar cell polarity contribute to the etiology of human neural tube defects | Birth Defects Research Part A: Clinical and Molecular Teratology | 2012 | 134 |
| 44 | Insights into metabolic mechanisms underlying folate‐responsive neural tube defects: A minireview | Birth Defects Research Part A: Clinical and Molecular Teratology | 2009 | 131 |
| 45 | Racial differences in gene‐specific DNA methylation levels are present at birth | Birth Defects Research Part A: Clinical and Molecular Teratology | 2011 | 131 |
| 46 | Paper 1: The EUROCAT network—organization and processes† | Birth Defects Research Part A: Clinical and Molecular Teratology | 2011 | 131 |
| 47 | In utero exposure to bisphenol-A and anogenital distance of male offspring | Birth Defects Research Part A: Clinical and Molecular Teratology | 2011 | 130 |
| 48 | Racial differences in infant mortality attributable to birth defects in the United States, 1989–2002 | Birth Defects Research Part A: Clinical and Molecular Teratology | 2006 | 129 |
| 49 | The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the centers for disease control and prevention | Birth Defects Research Part A: Clinical and Molecular Teratology | 2003 | 127 |
| 50 | First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: A meta‐analysis of epidemiological studies | Birth Defects Research Part A: Clinical and Molecular Teratology | 2010 | 126 |
